We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CME Group Outperforms Industry, Trades at a Premium: Hold Now?
Read MoreHide Full Article
Key Takeaways
CME delivers stability with varied products, steady revenue streams, and strong risk management practices.
CME Group projects 6.1% revenue growth and 6.2% earnings rise for 2026, with positive estimate revisions.
CME benefits from rising electronic trading, new products, and strong liquidity supporting dividends.
CME Group Inc. (CME - Free Report) is the largest futures exchange in the world in terms of both trading volume and notional value traded. Based in Chicago, IL, it has a market capitalization of $113.2 billion. The company offers a broad range of products across major asset classes, including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals.
CME benefits from a diversified product portfolio and robust risk management practices. The company also generates stable revenues from market data and operates on a reliable technology infrastructure. These factors, in unison, contribute to its overall stability, even during market fluctuations. As a result, it may be considered a viable option for long-term investment.
Share Price & Peer Performance
Shares of CME Group have risen 18% over the past year, outperforming the broader industry, which declined 1.8%. However, the stock has underperformed its peer Cboe Global Markets, Inc. (CBOE - Free Report) , which delivered stronger gains of 34.5% over the same period. CME Group has outperformed Deutsche Borse AG (DBOEY - Free Report) , which declined 2.5%, and Intercontinental Exchange, Inc. (ICE - Free Report) , which fell 7.4%.
Image Source: Zacks Investment Research
Valuation
CME Group is currently trading at a 12-month forward price-to-earnings (P/E) ratio of 26.06X, which is above the industry average of 22.42X.
Image Source: Zacks Investment Research
The stock is slightly more expensive than Cboe Global Markets, which trades at a forward P/E of 25.31X. However, it remains more expensive than Deutsche and Intercontinental Exchange, which trade at 20.57X and 20.51X, respectively. Based on this valuation, CME appears to be priced as a stable, high-quality exchange with a moderate growth profile.
Positive Analyst Outlook
For 2026, the Zacks Consensus Estimate implies revenue growth of 6.1% and an earnings improvement of 6.2%. The consensus estimate has moved north 1.1% over the past 30 days.
The bottom-line estimate for ICE and CBOE has seen upward revisions over the same time frame. DBOEY has witnessed no change in its earnings estimates during the said period.
What’s Driving CME?
CME Group continues to invest in initiatives that make it easier for clients to trade complex spread options electronically. The company is focusing on areas, such as organic growth in market data and the expansion of new products and services. Many of its past long-term investments are now delivering positive results. CME is also introducing new products to meet a wide range of customer needs.
CME has extended its exclusive Nasdaq futures license through 2029, ensuring continued access to the Nasdaq product suite for its clients. It is also building stronger connections between cash and futures markets through new offerings. Later this year, CME plans to launch BrokerTec Chicago. In May 2025, it introduced XRP futures, expanding its cryptocurrency derivatives lineup beyond Bitcoin, Ethereum and Solana.
Rising electronic trading volumes enhance scalability and provide greater operating leverage for CME Group. In 2025, over 90% of total contract volume was executed electronically via the CME Globex platform. Ongoing investments in upgrading its electronic trading infrastructure and broader technology capabilities are expected to enhance the company’s competitive positioning. CME Group anticipates strong trading activity, supported by elevated market volatility caused by uncertainty around tariff policies and geopolitical developments.
CME Group maintains a solid liquidity position. At the end of 2025, the company had $4.5 billion in cash and marketable securities. It held a long-term debt of $3.4 billion. This strong balance sheet supports steady capital returns and enhances investor confidence.
Since introducing its dividend policy in 2012, the company has returned approximately $30 billion to shareholders and consistently increased its dividend over time. The current dividend yield of 1.66% exceeds the industry average of 1.24%, making the stock attractive to income-focused investors.
Conclusion
CME Group is a strong and stable company. It delivers solid profitability, steady growth and reliable dividends. However, the upside from current levels appears limited. Rising competition, currency fluctuations and higher expenses could put pressure on future growth.
View the Zacks #1 Rank List
Image: Bigstock
CME Group Outperforms Industry, Trades at a Premium: Hold Now?
Key Takeaways
CME Group Inc. (CME - Free Report) is the largest futures exchange in the world in terms of both trading volume and notional value traded. Based in Chicago, IL, it has a market capitalization of $113.2 billion. The company offers a broad range of products across major asset classes, including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals.
CME benefits from a diversified product portfolio and robust risk management practices. The company also generates stable revenues from market data and operates on a reliable technology infrastructure. These factors, in unison, contribute to its overall stability, even during market fluctuations. As a result, it may be considered a viable option for long-term investment.
Share Price & Peer Performance
Shares of CME Group have risen 18% over the past year, outperforming the broader industry, which declined 1.8%. However, the stock has underperformed its peer Cboe Global Markets, Inc. (CBOE - Free Report) , which delivered stronger gains of 34.5% over the same period. CME Group has outperformed Deutsche Borse AG (DBOEY - Free Report) , which declined 2.5%, and Intercontinental Exchange, Inc. (ICE - Free Report) , which fell 7.4%.
Image Source: Zacks Investment Research
Valuation
CME Group is currently trading at a 12-month forward price-to-earnings (P/E) ratio of 26.06X, which is above the industry average of 22.42X.
Image Source: Zacks Investment Research
The stock is slightly more expensive than Cboe Global Markets, which trades at a forward P/E of 25.31X. However, it remains more expensive than Deutsche and Intercontinental Exchange, which trade at 20.57X and 20.51X, respectively.
Based on this valuation, CME appears to be priced as a stable, high-quality exchange with a moderate growth profile.
Positive Analyst Outlook
For 2026, the Zacks Consensus Estimate implies revenue growth of 6.1% and an earnings improvement of 6.2%. The consensus estimate has moved north 1.1% over the past 30 days.
The bottom-line estimate for ICE and CBOE has seen upward revisions over the same time frame. DBOEY has witnessed no change in its earnings estimates during the said period.
What’s Driving CME?
CME Group continues to invest in initiatives that make it easier for clients to trade complex spread options electronically. The company is focusing on areas, such as organic growth in market data and the expansion of new products and services. Many of its past long-term investments are now delivering positive results. CME is also introducing new products to meet a wide range of customer needs.
CME has extended its exclusive Nasdaq futures license through 2029, ensuring continued access to the Nasdaq product suite for its clients. It is also building stronger connections between cash and futures markets through new offerings. Later this year, CME plans to launch BrokerTec Chicago. In May 2025, it introduced XRP futures, expanding its cryptocurrency derivatives lineup beyond Bitcoin, Ethereum and Solana.
Rising electronic trading volumes enhance scalability and provide greater operating leverage for CME Group. In 2025, over 90% of total contract volume was executed electronically via the CME Globex platform. Ongoing investments in upgrading its electronic trading infrastructure and broader technology capabilities are expected to enhance the company’s competitive positioning. CME Group anticipates strong trading activity, supported by elevated market volatility caused by uncertainty around tariff policies and geopolitical developments.
CME Group maintains a solid liquidity position. At the end of 2025, the company had $4.5 billion in cash and marketable securities. It held a long-term debt of $3.4 billion. This strong balance sheet supports steady capital returns and enhances investor confidence.
Since introducing its dividend policy in 2012, the company has returned approximately $30 billion to shareholders and consistently increased its dividend over time. The current dividend yield of 1.66% exceeds the industry average of 1.24%, making the stock attractive to income-focused investors.
Conclusion
CME Group is a strong and stable company. It delivers solid profitability, steady growth and reliable dividends. However, the upside from current levels appears limited. Rising competition, currency fluctuations and higher expenses could put pressure on future growth.
Given the premium valuation, it is prudent to adopt a wait-and-see approach on this Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.